The chemical class of BRD7 Activators encompasses compounds that indirectly influence the activity of BRD7, a bromodomain-containing protein 7, primarily through modulation of related signaling pathways and cellular processes. These activators do not directly bind or interact with BRD7 but instead exert their effects on the cellular environment or on pathways that are interconnected with the functions of BRD7.
The chemicals listed, such as Resveratrol, Trichostatin A, and LY294002, operate through various mechanisms like enhancement of transcriptional activities, inhibition of specific kinases or enzymes, or modulation of cellular signaling molecules. For instance, Resveratrol enhances the activity of P53, which interacts with BRD7, thereby potentially increasing its activity. Trichostatin A, an HDAC inhibitor, affects chromatin remodeling, a process crucial for the gene regulatory functions of BRD7. LY294002, a PI3K inhibitor, alters AKT signaling pathways, indirectly affecting BRD7's role in these pathways. Other compounds like Forskolin and Rapamycin work by increasing cAMP levels and inhibiting mTOR, respectively, thereby influencing cellular processes and signaling pathways where BRD7 is involved. Similarly, Sodium Butyrate and Curcumin, through their actions as an HDAC inhibitor and a modulator of various signaling pathways, can impact BRD7's function in gene regulation and cellular response to inflammation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which is known to interact with BRD7, potentially enhancing BRD7's role in chromatin remodeling and gene expression regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can alter chromatin structure, possibly affecting BRD7's interaction with chromatin. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, similar to Trichostatin A, potentially influencing BRD7's chromatin interactions. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering DNA methylation patterns, which may indirectly influence BRD7's activity in gene regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP, which can modulate various signaling pathways potentially linked to BRD7 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to affect multiple signaling pathways and might influence BRD7 function indirectly through these pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
A compound found in cruciferous vegetables that affects various signaling pathways, possibly impacting BRD7 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, affecting AKT signaling, which may indirectly influence BRD7 activity in cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, potentially influencing pathways that intersect with BRD7's role in cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK pathway, possibly influencing BRD7 activity indirectly. | ||||||